Active	Status	Sponsor type	Region	Phase	Filter
5 Active 1 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Sharma, Vivek R
VIRAGE, NCT05673811: Study of Nab-Paclitaxel and Gemcitabine and Plus/minus VCN-01 in Patients with Metastatic Pancreatic Cancer	Active, not recruiting	2	96	Europe, US	Nab-paclitaxel, Gemcitabine, VCN-01	Theriva Biologics SL	Pancreatic Adenocarcinoma, Metastatic	04/25	04/25
ASIST, NCT05322590: BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma	Active, not recruiting	1/2	195	US	BXQ-350, SapC-DOPS, Placebo	Bexion Pharmaceuticals, Inc., ICON plc, CTI Clinical Trial and Consulting Services	Metastatic Colorectal Carcinoma, Neuropathy	04/26	04/29
NCT03994627: Olaratumab (LY3012207) Patient Access for Soft Tissue Sarcoma	Approved for marketing	N/A		Europe, Canada, US, RoW	Olaratumab, LY3012207	Eli Lilly and Company	Soft Tissue Sarcoma